Mobile Menu - OpenMobile Menu - Closed

Markup of H.R. 1222, H.R. 2410, and H.R. ____, FDA Reauthorization Act of 2017, Subcommittee on Health (May 18, 2017)

Date: 
Thursday, May 18, 2017 - 10:00am
Location: 
2123 Rayburn House Office Building
Subcommittees: 

The Subcommittee on Health met in open markup session on Thursday, May 18, 2017, at 10:00 a.m., in 2123 Rayburn House Office Building.

 

 

Livestream

   

Key Documents

Memorandum from Ranking Member Pallone to the Subcommittee on Health 

Opening Statement of Ranking Member Pallone as prepared for delivery

Preliminary Transcript

 

Legislation

H.R. 1222, Congenital Heart Futures Reauthorization Act of 2017 was adopted, as amended, by a voice vote

  Amendment in the Nature of a Substitute offered by Rep. Bilirakis was adopted by a voice vote

 

H.R. 2410, Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017 was adopted by a voice vote

 

H.R. 2430  FDA Reauthorization Act of 2017 was adopted, as amended, by a voice vote

  Amendment offered by Reps. Kennedy and Blackburn was adopted by a voice vote

  Amendment offered by Reps. Butterfield, Bucshon, and Brooks was adopted by a voice vote  

  Amendment  offered by Reps. Green, Burgess, and Lance was adopted by a voice vote

  Amendment  offered by Reps. Schrader and Bilirakis was adopted by a voice vote

 

Issues: